Characterization of Cardiac Conduction System Abnormalities in Mice with Targeted Disruption of Six5 Gene

Springer Science and Business Media LLC - Tập 7 - Trang 127-135 - 2002
Hiroko Wakimoto1, Colin T. Maguire1, Megan C. Sherwood1,2, Marcel M. Vargas1, Partha S. Sarkar3, Jennifer Han3, Sita Reddy3, Charles I. Berul1
1Department of Cardiology, Children’s Hospital, Boston, USA
2Department of Pediatrics, Harvard Medical School, Boston, USA
3Institute for Genetic Medicine, University of Southern California School of Medicine, Los Angeles, USA

Tóm tắt

Myotonic dystrophy (DM) is an autosomal dominant multisystem disorder, caused by expansion of a CTG trinucleotide repeat in the 3′ untranslated region of the myotonic dystrophy protein kinase gene (DMPK) on chromosome 19q13. Cardiac involvement in DM includes conduction abnormalities and functional deficits. Three hypotheses of molecular mechanisms for DM pathophysiology are; first, partial loss of myotonic dystrophy protein kinase (DMPK); second, decreased transcription of a neighboring homeodomain-encoding gene, Six5 (or DMAHP), and third, transdominant effects of the RNA and regulation of splicing associated with expression of expanded CUG repeats. However, the precise pathogenetic mechanism remains unresolved. We previously reported that dosage of Dm15, the mouse homologue of DMPK, strongly associates with the cardiac conduction abnormalities. For further distinction of the molecular mechanisms underlying the cardiac phenotype of DM, in the present study, we characterized the cardiac conduction findings of mice with targeted disruption of Six5 gene. Six5 heterozygous mice (adult and young) and their age matched wild type littermates were studied using in vivo electrophysiologic techniques, echocardiography, heart rate variability and exercise tolerance testing. No PR prolongation was detected, however, prolonged QRS duration and delayed infraHisian conduction were significant in adult Six5 heterozygous mice. By echocardiography, left ventricular (LV) end-diastolic dimension was enlarged in adult Six5 heterozygous mice, although neither fractioning shortening nor LV wall thickness showed significant differences. Six5 loss may partly contribute to conduction abnormalities in myotonic dystrophy, particularly infraHisian conduction delay, one of the initial phenotypes of adult-onset cardiac conduction abnormalities in DM patients.

Từ khóa


Tài liệu tham khảo

Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, Hunter K, Stanton VP, Thirion JP, Hudson T, Sohn R, Zemelman B, Snell RG, Rundle SA, Crow S, Davies J, Shelbourne P, Buxton J, Jones C, Juvonen V, Johnson K, Harper PS, Shaw DJ, Housman DE. Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3-prime end of a transcript encoding a protein kinase family member. Cell 1992;68:799–808.

Harley HG, Brook JD, Rundle SA, Crow S, Reardon W, Buckler AJ, Harper PS, Housman DE, Shaw DJ. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 1992;355:545–546.

Fu YH, Pizzuti A, Fenwick RG, King J, Rajnarayan S, Dunne PW, Dubel J, Nasser GA, Ashizawa T, de Jong P, Wieringa B, Korneluk R, Perryman M, Epstein HF, Caskey CT. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992;255:1256–1258.

Buxton J, Shelbourne P, Davies J, Jones C, Van Tongeren T, Aslanidis C, de Jong P, Jansen G. Anvret M, Riley B, Williamson R, Johnson K. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 199;355:547–548. Cardiac Conduction in Six5 Mutant Mice 135

Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G, Neville C, Narang M, Barcelo J, O'Hoy K, Leblond S, Earle-Macdonald J, de Jong PJ, Wieringa B, Korneluk RG. Myotonic dystrophy mutation: An unstable CTG repeat in the 3-prime untranslated region of the gene. Science 1992;255:1253–1255.

Harper PS. Myotonic Dystrophy, 2nd ed. W.B. Saunders: Philadelphia, 1989.

Tokgozoglu LS, Ashizawa T, Pacifico A, Armstrong RM, Epstein HF, Zoghbi WA. Cardiac involvement in a large kindred with myotonic dystrophy: Quantitative assessment and relation to size of CTG repeat expansion. J.A.M.A. 1995;274:813–819.

Hayashi Y, Ikeda U, Kojo T, Nishinaga M, Miyashita H, Kuroda T, Inoue K, Nishizawa M, Shimada K. Cardiac abnormalities and cytosine-thymine-guanine trinucleotide repeats in myotonic dystrophy. Am Heart J 1997;134:2292–297.

Taneja KL, McCurrach M, Schalling M, Housman D, Singer RH. Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J Cell Biol 1995;128:995–1002.

Davis BM, McCurrach ME, Taneja KL, Singer RH, Housman DE. Expansion of a CUG trinucleotide repeat in the 3' untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc Natl Acad Sci USA 1997;94:7388–7393.

Berul CI, Maguire CT, Aronovitz MJ, Greenwood J, Miller C, Gehrmann J, Housman D, Mendelsohn ME, Reddy S. DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model. J Clin Invest 1999;103:R1–7.

Reddy S, Smith DB, Rich MM, Leferovich JM, Reilly P, Davis BM, Tran K, Rayburn H, Bronson R, Cros D, Balice-Gordon RJ, Housman D. Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nature Genet 1996;13:325–335.

Klesert TR, Cho DH, Clark JI, Maylie J, Adelman J, Snider L, Yuen EC, Soriano P, Tapscott SJ. Mice deficient in Six5 develop cataracts: Implications for myotonic dystrophy. Nat Genet 2000;25:105–109.

Sarkar PS, Appukuttan B, Han J, Ito Y, Ai C, Tsai W, Chai Y, Stout JT, Reddy S. Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts. Nat Genet 2000;25:110–114.

Philips AV, Timchenko LT, Cooper TA. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 1998;280:737–741.

Mankodi A, Logigian E, Callahan L, McClain C, White R, Henderson D, Krym M, Thornton CA. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 2000;289:1769–1773.

Saba S, VanderBrink BA, Luciano B, Aronovitz MJ, Berul CI, Reddy S, Housman D, Mendelsohn ME, Estes NAM, Wang PJ. Localization of the sites of conduction abnormalities in a mouse model of myotonic dystrophy. J Cardiovasc Electrophysiol 1999;10:1214–1220.

Heath SK, Carne S, Hoyle C, Johnson KJ, Wells DJ. Characterisation of expression of mDMAHP, a homeodomainencoding gene at the murine DM locus. Hum Mol Genet 1997 6:651–657.

Thornton CA, Wymer JP, Simmons Z, McClain C, Moxley RT III. Expansion of the myotonic dystrophy CTG repeat reduces expression of the flanking DMAHP gene. Nature Genet 1997;16:407–409.

Klesert TR, Otten AD, Bird TD, Tapscott SJ. Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP. Nat Genet 1997;16:402–406.

Berul CI, Aronovitz MJ, Wang PJ, Mendelsohn ME. In vivo cardiac electrophysiology studies in the mouse. Circulation 1996;94:2641–2648.

Mitchell GF, Jeron A, Koren G. Measurement of heart rate and Q-T interval in the conscious mouse. Am J Physiol 1998;274:H747–751.

Wakimoto H, Maguire CT, Kovoor P, Hammer PE, Gehrmann J, Triedman JK, Berul CI. Induction of atrial tachycardia and fibrillation in the mouse heart. Cardiovasc Res 2001;50:463–473.

Gehrmann J, Hammer PE, Maguire CT, Wakimoto H, Triedman JK, Berul CI. Phenotypic screening for heart rate variability in the mouse. Am J Physiol 2000;279:H733–740.

Berul CI, Maguire CT, Gehrmann J, Reddy S. Progressive atrioventricular conduction block in a mouse myotonic dystrophy model. J Interv Card Electrophysiol 2000;4:351–358.

Lieberman AP, Fischbeck KH. Triplet repeat expansion in neuromuscular disease. Muscle Nerve 2000;23:843–850.

Antonini G, Giubilei F, Mammarella A, Amicucci P, Fiorelli M, Gragnani F, Morino S, Ceschin PV, Fragola PV, Gennarelli M. Natural history of cardiac involvement in myotonic dystrophy: Correlation with CTG repeats. Neurology 2000;55:1207–1209.

Babuty D, Fauchier L, Tena-Carbi D, Poret P, Leche J, Raynaud M, Fauchier JP, Cosnay P. Is it possible to identify infrahissian cardiac conduction abnormalities in myotonic dystrophy by non-invasive methods? Heart 1999;82:634–637.

Ohto H, Kamada S, Tago K, Tominaga SI, Ozaki H, Sato S, Kawakami K. Cooperation of six and eya in activation of their target genes through nuclear translocation of Eya. Mol Cell Biol 1999;19:6815–24.

Benders AA, Timmermans JA, Oosterhof A, Ter Laak HJ, van Kuppevelt TH, Wevers RA, Veerkamp JH. Deficiency of Na+/K(+)-ATPase and sarcoplasmic reticulum Ca(2+)-ATPase in skeletal muscle and cultured muscle cells of myotonic dystrophy patients. Biochem J 1993;293:269–274.

Benders AA, Wevers RA, Veerkamp JH. Ion transport in human skeletal muscle cells: Disturbances in myotonic dystrophy and Brody's disease. Acta Physiol Scand 1996;156:355–367.

Anand IS, Florea VG. High Output Cardiac Failure. Current Treat Options Cardiovasc Med2001;3:151–159.

Fragola PV, Luzi M, Calo L, Antonini G, Borzi M, Frongillo D, Cannata D. Cardiac involvement in myotonic dystrophy. Am J Cardiol 1994;74:1070–1072].

Bu'Lock FA, Sood M, De Giovanni JV, Green SH. Left ventricular diastolic function in congenital myotonic dystrophy. Arch Dis Child 1999;80:267–270.